Canadian delegation to showcase investment opportunities to India
The delegation will visit Bengaluru and Mumbai from November 26 to 30
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Lupin launches chatbot ANYA
ANYA is the first bot of its kind to be launched in India for disease awareness
ABLE’s BioEconomy Conclave to be held in Bengaluru
The two-day conclave from January 31 to Febrauary 1, will have nine sessions dedicated to different segments of bioeconomy
Strides board approves $15 m investment in Stelis Biopharma
The first close of the current fund raise is $35 million, of which Strides will commit $15 million and $20 million is from other…
Roche-AbbVie cancer drug gets accelerated FDA approval
The drug, developed in partnership with AbbVie, was approved for patients with acute myeloid leukemia
US FDA approves new blood cancer treatment from Pfizer
The company plans to launch the drug, Daurismo, in the US by early December with a monthly list price of $16,925
Indoco’s Goa Plant II & III clears US FDA inspection
This positive development will now pave the way for approval of our pending ANDAs with consequent boost to revenues from the US…
Environmental exposures early in life modify immune responses
Studies have shown that immunological development and maturation starts already during pregnancy and in early childhood
Glenmark receives ANDA approval for Atovaquone Oral Suspension USP, 750 mg/5 mL
The drug is the generic version of Mepron 1 Oral Suspension, 750 mg/5 mL, of GlaxoSmithKline
Piramal Pharma Solutions unveils cGMP kilo lab suite for API
The suite in Chennai will formally open on December 1, 2018
US court rules in favour of DRL on generic Suboxone
A patent infringement case was filed by pharma giant Indivior on selling generic version of Suboxone
Dr Reddy's Laboratories…
Lupin launches generic of Xenazine in US
The company has received approval from US FDA earlier this year
Handful of pharma companies developing urgently needed new medicines for poor: The Access to…
The analysis indicates that the majority of the priority R&D projects are being carried out with public sector research…
ICT to organise 2nd Biosimilar Workshop 2018 in Mumbai
The event will be conducted in collaboration with US Pharmacopeia, BIRAC, C-CAMP and ABLE
Institute of Chemical Technology (ICT)…
Glenmark gets US FDA nod for generic acne treatment gel
The approval granted is for Azelaic Acid Gel, 15 per cent, which is a generic version of Finacea Gel (15 per cent) of Leo Pharma
Vinod P Shah, International Chairman, SPDS, bags recognition from AAPS
Shah has conclusively demonstrated his vision, passion, and commitment to advancing treatments and cures that improve the quality…
AstraZeneca India, Business Sweden launch ‘Unnati Healthcare 2.0 – Innovation Challenge’
Unnati Healthcare 2.0 is a multi-partner initiative with a shared vision of encouraging innovative solutions that can impact the…
Concomitant usage of sleeping pills and painkillers is common among people with AD
In high-risk patient groups, concomitant use of opioids and benzodiazepines or related drugs may increase the risk of pneumonia,…
Chief of Pharma Pricing Authority exhorts industry to exercise self-regulation at CII Pharma Summit
CII’s Pharmaceuticals Committee acts as an enabler to foster growth opportunities in the sector
Aurobindo Pharma to launch oncology, respiratory products in US by 2021
The company plans to launch first set of biosimilars and vaccines in growth markets during this time